Insmed

INSMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$26.424 B

$121.00 +0.83%

Close of 21 Sept 2026

Revenue

$606.4M

#1811 by revenue

Earnings

-$1.28B

Loss-making

Shares outstanding

218,381,503

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#20ZoetisZTS$29.5B
#21Roivant SciencesROIV$28.2B
#22InsmedINSM$26.4B
#23United TherapeuticsUTHR$21.1B
#24ViatrisVTRS$19.6B

What if Insmed were worth as much as…

Open the what-if tool →

Gold $30.3T

$138,629.20

Per share 1,146× higher

Bitcoin $1.72T

$7,875.23

Per share 65.1× higher

Nvidia $5.48T

$25,093.05

Per share 207× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Insmed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.